Singapore markets closed
Straits Times Index
3,212.64 -6.36 (-0.20%) Nikkei
27,385.25 -34.36 (-0.13%) Hang Seng
19,915.68 -133.96 (-0.67%) FTSE 100
7,356.71 -142.89 (-1.91%) Bitcoin USD
28,015.53 +405.48 (+1.47%) CMC Crypto 200
611.11 +13.65 (+2.28%)
Swedish Orphan Biovitrum AB (publ) (BIOVF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 11:10AM EDT
| Previous close | 23.11 |
| Open | 23.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 23.11 - 23.11 |
| 52-week range | 18.25 - 24.50 |
| Volume | |
| Avg. volume | 303 |
| Market cap | 7.025B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 23.82 |
| EPS (TTM) | 0.97 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Apellis' (APLS) Earnings Top, Empaveli Sales Boost Revenues
Apellis Pharmaceuticals (APLS) reports better-than-expected results, beating both earnings and revenue estimates. Empaveli sales continue to boost product revenues for the company.
- Zacks
Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates
Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year?
Here is how Alimera Sciences (ALIM) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year.
© 2023 Yahoo. All rights reserved.
